The Number of Sentinel Lymph Nodes Could be Optimized by Adjusting the Injection Dose

Main Article Content

Masujiro Makita
Eriko Manabe
Michiko Sato
Hiroyuki Takei


Sentinel node biopsy, Superparamagnetic iron oxide nanoparticles (SPIO), Neodymium magnet , Magnetometer


Background: The optimal number of sentinel lymph nodes (SLNs) to be removed is controversial based on the false negative rate and prognosis. We investigated factors related to the number of SLNs and the possibility of optimizing the number of SLNs.
Methods: We retrospectively reviewed 167 cases in which 0.3 or 0.5 ml of ferucarbotran was sub-dermally injected without massage from July 2016 to November 2018. Sentinel lymph node biopsy (SNB) was conducted using both radioisotope (RI) and superparamagnetic iron oxide (SPIO). The removed nodes with a value of ?0.5 ?T on a magnetometer were considered to be SLNs (SPIO nodes). The total SPIO node count in each case was calculated.
Results: There was a significant correlation between the number of SPIO nodes and total count of SPIO nodes (rs=0.821, p<0.0001). With RI and SPIO methods, the average number of removed nodes in the age?75 years and BMI?25 subgroups was significantly lower than that in the age<75 years and BMI<25 subgroups. The number of SPIO nodes was significantly influenced by the injected dose. The average number of SPIO nodes in the age ?75 years and BMI?25 subgroups after injection of 0.5 ml was almost the same as that of the age <75 years and BMI<25 subgroups after injection of 0.3 ml.
Conclusion: Obesity and old age seemed to be associated with slow lymphatic flow; however, increasing the dose increased the number of SPIO nodes. Thus, optimization of the number of SLNs seems possible.


1. Noguchi M. Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience. Breast Cancer. 2001;8(3):184-94.
2. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106(1):4-16.
3. Shiozawa M, Lefor AT, Hozumi Y, Kurihara K, Sata N, et al. Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer. Breast Cancer. 2013;20(3):223-9.
4. Makita M, Manabe E, Kurita T, Takei H, Nakamura S, et al. Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer. BMC Med Imaging. 2020;20(1):58.
5. Derossis AM, Fey JV, Cody HS, 3rd, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003;197(6):896-901.
6. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, et al. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nuclear medicine communications. 2003;24(6):663-70.
7. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, et al. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging. 2005;32(3):286-93.
8. Goyal A, Newcombe RG, Chhabra A, Mansel RE, Group AT. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99(2):203-8.
9. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392-9.
10. Krag DN, Weaver DL, Alex JC, Fairbank J, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surgical oncology. 1993;2(6): 335-40.
11. Martin RC, 2nd, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Surgery. 2000;128(2):139-44.
12. Schrenk P, Rehberger W, Shamiyeh A, Wayand W. Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node? Journal of surgical oncology. 2002;80(3): 130-6.
13. Yi M, Meric?Bernstam F, Ross MI, Akins JS, Hwang RF, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008; 113(1):30-7.
14. Ban EJ, Lee JS, Koo JS, Park S, Kim SI, et al. How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer? Journal of breast cancer. 2011;14(4):296-300.
15. Bonneau C, Bendifallah S, Reyal F, Rossi L, Rouzier R. Association of the number of sentinel lymph nodes harvested with survival in breast cancer. Eur J Surg Oncol. 2015;41(1):52-8.
16. Han C, Yang B, Zuo W-S, Liu Y-S, Zheng G, et al. Prospective study found that peripheral lymph node sampling reduced the false-negative rate of sentinel lymph node biopsy for breast cancer. Chinese Journal of Cancer. 2016;35(1):35.
17. Kim MK, Park HS, Kim JY, Kim S, Nam S, et al. The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer. Am J Surg. 2017;214(4):726-32.
18.Karakatsanis A, Daskalakis K, Stålberg P, Olofsson H, Andersson Y, et al. Superparam-agnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. British Journal of Surgery. 2017;104(12):1675-85.
19. Bass SS, Cox CE, Salud CJ, Lyman GH, McCann C, et al. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. Journal of the American College of Surgeons. 2001;192(1):9-16.